Replies to post #17978 on GTC Biotherapeutics (fka GTCB)

[DewDiligence]

Just to be clear: PharmAthene’s Protexia is not a mAb, and mAbs are what I thought we were talking about in this thread. PharmAthene does have a mAb in its pipeline called Valtorim, which is intended to fight Anthrax infection; however, Valtorim is not produced using transgenics. Regards, Dew